Skip to main content
Top
Published in: Critical Care 1/2019

Open Access 01-12-2019 | Chronic Obstructive Lung Disease | Letter

Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do

Authors: Yuetian Yu, Chunyan Liu, Zhongheng Zhang, Hui Shen, Yujie Li, Liangjing Lu, Yuan Gao

Published in: Critical Care | Issue 1/2019

Login to get access

Excerpt

The development of bronchoscopy and bronchoalveolar lavage (BAL) has led to an increase in their use in intensive care units (ICUs), where their applications for differential diagnosis of pulmonary diseases make them indispensable instruments for intensivists [1]. Despite their common use, a few studies have raised concerns about potential impacts on bronchoalveolar lavage fluid (BALF) dilution, which affects mainly the quantitative detection of soluble substances. Urea is a diffusible substance that can easily be detected in capillaries and alveolar spaces. The urea concentration in plasma and that in BALF are approximately equal and their ratio (urea plasma/urea BALF) has previously been applied as an index of BALF dilution. Furthermore, it has been shown that the ratio of high-quality lavage is low in clinical settings [2, 3]. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Ergan B, Nava S. The use of bronchoscopy in critically ill patients: considerations and complications. Expert Rev Respir Med. 2018;12:651–63.CrossRef Ergan B, Nava S. The use of bronchoscopy in critically ill patients: considerations and complications. Expert Rev Respir Med. 2018;12:651–63.CrossRef
2.
go back to reference Baughman RP. The uncertainties of bronchoalveolar lavage. Eur Respir J. 1997;10:1940–2.CrossRef Baughman RP. The uncertainties of bronchoalveolar lavage. Eur Respir J. 1997;10:1940–2.CrossRef
3.
go back to reference Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004–14.CrossRef Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004–14.CrossRef
4.
go back to reference Roux D, Reignier J, Thiery G, Boyer A, Hayon J, Souweine B, et al. Acquiring procedural skills in ICUs: a prospective multicenter study. Crit Care Med. 2014;42:886–95.CrossRef Roux D, Reignier J, Thiery G, Boyer A, Hayon J, Souweine B, et al. Acquiring procedural skills in ICUs: a prospective multicenter study. Crit Care Med. 2014;42:886–95.CrossRef
5.
go back to reference Yu Y, Zhu C, Gao Y. Bronchoalveolar lavage fluid galactomannan as a diagnostic biomarker for IPA: still a long way to go. Crit Care. 2016;20:280.CrossRef Yu Y, Zhu C, Gao Y. Bronchoalveolar lavage fluid galactomannan as a diagnostic biomarker for IPA: still a long way to go. Crit Care. 2016;20:280.CrossRef
Metadata
Title
Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do
Authors
Yuetian Yu
Chunyan Liu
Zhongheng Zhang
Hui Shen
Yujie Li
Liangjing Lu
Yuan Gao
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2019
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-018-2300-x

Other articles of this Issue 1/2019

Critical Care 1/2019 Go to the issue